Skip to content

T.E.A.L. funds a $25,000 Ovarian Cancer Research Grant at Johns Hopkins School of Medicine

T.E.A.L.® is excited to announced its newest partnership with the Kelly Gynecological Oncology Service at Johns Hopkins School of Medicine. T.E.A.L.® funded a $25,000 grant towards the Characterization of the Genomic Profile of BRCA Negative Hereditary Breast and Ovarian Cancer, a study conducted at the University led by Dr. Kara Long.
Dr. Long’s study will evaluate increased risk of breast and ovarian cancer in women who do not test positive for the BRCA gene mutation. It is known that women who test positive for the BRCA mutation are at an increased risk of breast and ovarian cancer, but the majority of women diagnosed with ovarian cancer do not have these gene mutations. There is still much work to be done in identifying genes and factors that cause ovarian cancer in the majority of those diagnosed, who are women who do not test positive for BRCA and have no identifiable BRCA mutation.  T.E.A.L.® is thrilled to be a part of this cutting edge research. Stay tuned for updates on the project.

Check out some more of T.E.A.L.®’s achievements here!

Help us reach our end of year goal!

With 251 members in our Tell Every Amazing Lady® Survivor Program across 37 states and more than 22,000 women served globally, our programs make a huge impact. But we can’t do it alone. Donate today to help us reach our $200,000 goal before the end of the year!

0
    0
    Your Cart
    Your cart is emptyReturn to Shop